Intra-cellular therapies to present at three upcoming investor conferences

New york, aug. 28, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at three upcoming investor conferences:
ITCI Ratings Summary
ITCI Quant Ranking